Autonomix Medical AMIX
Medical - Instruments & Supplies, Healthcare
$1.68
−7.18%
- Market cap
- $1.6M
- PE
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- n/m
- not a meaningful number
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- n/m
- not a meaningful number
- Net margin
- n/m
- not a meaningful number
- Free cash flow yield
- n/m
- Q1 FY27 missing
Charts
Financials
| Income statement | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D | $471K | $687K+245% | $698K+72% | $954K+159% | $1.2M+149% | $1M+52% | $1.6M+123% | $1.6M+67% | $2.4M+102% | $1.7M+65% | $1.5M−6% | $1.5M−5% |
| SG&A | $793K | $2.2M+548% | $1.7M+587% | $1.8M+258% | $1.7M+110% | $1.7M−24% | $1.7M−1% | $1.8M+2% | $5.2M+211% | $1.6M−5% | $1.3M−25% | $1.3M−31% |
| −$5.8M | −$2.9M+438% | −$2.4M+268% | −$2.8M+216% | −$2.8M−51% | −$2.7M−6% | −$3.3M+35% | −$3.4M+24% | −$7.5M+166% | −$3.3M+22% | −$2.7M−16% | −$2.8M−19% | |
| Interest expense | $0 | $33K | $46K | $41K | $43K | $45K+36% | $46K+0% | $0 | $0 | $0 | $0 | n/a |
| Pre-tax income | −$6M | −$3.1M+472% | −$5.4M+723% | −$2.7M+212% | −$2.8M−54% | −$2.7M−13% | −$3.2M−41% | −$3.3M+24% | −$7.5M+165% | −$3.3M+20% | −$2.7M−17% | −$2.7M−18% |
| $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net income | −$6M | −$3.1M+472% | −$5.4M+723% | −$2.7M+212% | −$2.8M−54% | −$2.7M−13% | −$3.2M−41% | −$3.3M+24% | −$7.5M+165% | −$3.3M+20% | −$2.7M−17% | −$2.7M−18% |
| n/a | −$63.84+5980% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| n/a | 657.1K+15% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EPS, diluted: Q3 FY23 and Q3 FY24: quarter's net income to common over its shares, to the cent.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Healthcare nearest Autonomix Medical's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| AMIXAutonomix Medical | $1.6M | n/m | n/a | n/m | n/m | n/m | |
| OXBROXBRIDGE RE HOLDINGS | $6.5M | 40.2× | 9.8× | 2.4× | +40% | 4.7% | |
| EDUCEducational Development | $8.9M | 5.5× | 11.3× | 0.4× | −32% | 8.6% | |
| GTIMGood Times Restaurants | $14M | 6.3× | 13.5× | 0.1× | −6% | 1.7% | |
| Peer median | $8.9M | 6.3× | 11.3× | 0.4× | −6% | 4.7% |
More on Autonomix Medical
Each number over time
Its groups
About
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .